Your Messages Inbox
Your Article Summary
See Latest ArticlesUS FDA approves Extavia - the first in a new portfolio of planned MS therapies from Novartis to help patients with this devastating disease
Novartis, 08/18/09
The US Food and Drug Administration has approved Extavia, the first in a new planned portfolio of multiple sclerosis medicines from Novartis to help patients manage this devastating disease.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor